Description
AOD-9604 5mg — modified GH fragment for lipolysis research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
AOD-9604 is a modified fragment of human growth hormone comprising amino acids 177-191. Developed at Monash University in Australia, it includes a tyrosine modification enhancing stability while retaining lipolytic activity.
What the Research Shows
Research has examined AOD-9604’s effects on lipid metabolism — stimulating lipolysis and inhibiting lipogenesis in adipose tissue models. Its mechanism appears distinct from the growth-promoting effects of full-length GH.
Studies show effects on fat metabolism without impacts on insulin sensitivity or IGF-1 levels. Additional research explores cartilage repair through effects on chondrocyte proliferation and matrix synthesis.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity. No generic overseas certificates.
→ Explore the Peptide Research Library
Purity: ≥99% (HPLC)
Form: Lyophilised powder
Molecular Weight: 1815.08 Da
CAS: 221231-10-3
Sequence: hGH fragment 177-191 (modified)
Research: PubMed
▸ Australian university verified
▸ ≥99% purity guaranteed
▸ Same-day dispatch from Sydney
▸ Research-grade lyophilised powder
Related Research and Resources
For research use only. Not for human consumption.




